DNAJB1 and multiple sclerosis: Based on outcomes of computing binding affinity between bioactive compounds of Royal jelly and macromolecules involved in multiple sclerosis network with the highest degree and betweenness centrality by molecular docking practice, we concluded that all of the ten bioactive compounds of Royal jelly in this bioinformatics study bind to DNAJB1 and TNFSF14 with suitable binding affinity and acceptable RMSD threshold.